Question 1

What are the potential side effects of the SOL treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China clinical trial (NCT01110941). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China clinical trial (NCT01110941). Contact the study team or your healthcare provider for specific answers.

Question 3

What tests will I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China clinical trial (NCT01110941). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic for treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China clinical trial (NCT01110941). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience severe side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China clinical trial (NCT01110941). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China clinical trial (NCT01110941). Contact the study team or your healthcare provider for specific answers.

What this study is about